The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years

Journal of Rheumatology

Volumn 27, Issue 11, 2000, Pages 2566-2575

  Rau, R ^a   Herborn, G ^a   Zueger, S ^a   Fenner, H ^a  

^a Rheumaklinik   (Germany)

Author keywords

DMARD treatment; HLA DRB1 genes; Longterm study; Radiographic progression; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; HLA DR1 ANTIGEN; METHOTREXATE; RHEUMATOID FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; TREATMENT OUTCOME;

ALLELES; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GENE FREQUENCY; GOLD SODIUM THIOMALATE; HLA-DR ANTIGENS; HUMANS; MALE; METHOTREXATE; RHEUMATOID FACTOR;

EID: 0033737685     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Immunogenetic heterogeneity of rheumatoid arthritis
2. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis
3. HLA-DR4 and other genetic markers in rheumatoid arthritis
4. Destructive arthritis, rheumatoid factor, and HLA-DR4
5. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis
6. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis
7. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis - Their relation to disease progression
8. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
9. Disease mechanisms in rheumatoid arthritis: Gene dosage effect of HLA-DRB1 haplotypes
10. Major histo-compatibility complex variants and articular disease severity in rheumatoid arthritis
11. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
12. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
13. Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA
14. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage
15. HLA-DRB1 *0401/0404 genotype in rheumatoid arthritis: Increased association in men, young age at onset, and disease severity
16. Association of shared epitope with radiological severity of rheumatoid arthritis
17. HLA-DRB1 genes and disease severity in rheumatoid arthritis
18. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis
19. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city-wide community based study
20. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
21. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis
22. HLA-DRB1 genes, rheumatoid factor and elevated CRP: Independent risk factors of radiographic progression in early RA
23. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis
24. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis
25. A new method of scoring radiographic changes in rheumatoid arthritis
26. Rapid HLA-DRB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes
27. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes
28. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis
29. Low dose prednisolone therapy retards radiographically detectable destruction in early rheumatoid arthritis
30. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: The HLA-DRB shared-epitope hypothesis accounts for the disease in only a minority of Greek patients
31. Polymyalgia rheumatica and seronegative rheumatoid arthritis: Some considerations based on a northern Italian population
32. Morbidity and mortality in rheumatoid arthritis over 5 years according to 2, 1 or 0 HLA-DR4 alleles by serotyping
33. Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar
34. Disease mechanisms in rheumatoid arthritis: Gene dosage effect of HLA-DR haplotypes
35. Prognosis in rheumatoid arthritis: Applying new technologies to old questions
36. Should patients with recent onset rheumatoid arthritis be offered genetic screening?
37. Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis
38. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease